ArticleFrontiers in pharmacology2026
GuiLingJi ameliorates mild cognitive impairment by targeting unsaturated fatty acid metabolism to inhibit GPR120/NF-κB mediated neuroinflammation.
Jingchao Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.